Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Amazon
AMZN
|
+$623M |
| 2 |
PayPal
PYPL
|
+$425M |
| 3 |
Union Pacific
UNP
|
+$325M |
| 4 |
AbbVie
ABBV
|
+$300M |
| 5 |
Intel
INTC
|
+$295M |
Top Sells
| 1 |
Apple
AAPL
|
+$511M |
| 2 |
Wells Fargo
WFC
|
+$273M |
| 3 |
Pinterest
PINS
|
+$270M |
| 4 |
Pfizer
PFE
|
+$267M |
| 5 |
HP
HPQ
|
+$246M |
Sector Composition
| 1 | Technology | 21.27% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IFFT
2001
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $1.11M | ﹤0.01% |
25,000
| – | – |
|
2002
Akebia Therapeutics
AKBA
$769M
| $1.11M | ﹤0.01% |
441,126
+165,178
| +60% | +$415K |
|
|
VRAY
2003
DELISTED
ViewRay, Inc.
VRAY
| $1.11M | ﹤0.01% |
316,450
-2,913
| -0.9% | -$10.2K |
|
|
CIT
2004
DELISTED
CIT Group Inc.
CIT
| $1.1M | ﹤0.01% |
62,282
+8,015
| +15% | +$142K |
|
|
CXP
2005
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.1M | ﹤0.01% |
101,068
+11,542
| +13% | +$126K |
|
2006
Cerence
CRNC
$512M
| $1.1M | ﹤0.01% |
22,483
-59,302
| -73% | -$2.9M |
|
2007
Myriad Genetics
MYGN
$715M
| $1.1M | ﹤0.01% |
84,284
+24,194
| +40% | +$315K |
|
2008
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.37B
| $1.1M | ﹤0.01% |
25,000
| – | – |
|
2009
LPL Financial
LPLA
$27.4B
| $1.1M | ﹤0.01% |
14,336
-1,267,236
| -99% | -$97.1M |
|
2010
iShares Global Tech ETF
IXN
$6.14B
| $1.1M | ﹤0.01% |
24,918
-28,176
| -53% | -$1.24M |
|
2011
Opko Health
OPK
$1.17B
| $1.1M | ﹤0.01% |
296,789
+54,138
| +22% | +$200K |
|
2012
Columbia Banking Systems
COLB
$7.97B
| $1.09M | ﹤0.01% |
45,745
+3,345
| +8% | +$79.9K |
|
2013
EPR Properties
EPR
$4.34B
| $1.09M | ﹤0.01% |
39,629
+6,712
| +20% | +$184K |
|
2014
Editas Medicine
EDIT
$268M
| $1.09M | ﹤0.01% |
38,812
-977
| -2% | -$27.4K |
|
2015
Openlane
KAR
$3.12B
| $1.09M | ﹤0.01% |
75,379
-47,429
| -39% | -$683K |
|
2016
Dynavax Technologies
DVAX
$1.15B
| $1.08M | ﹤0.01% |
250,722
-504,248
| -67% | -$2.18M |
|
2017
MGP Ingredients
MGPI
$589M
| $1.08M | ﹤0.01% |
27,251
-17,458
| -39% | -$694K |
|
2018
Amkor Technology
AMKR
$7.1B
| $1.08M | ﹤0.01% |
96,541
+41,793
| +76% | +$468K |
|
2019
Transmedics
TMDX
$4.12B
| $1.08M | ﹤0.01% |
78,327
+21,643
| +38% | +$298K |
|
2020
The GEO Group
GEO
$3.11B
| $1.08M | ﹤0.01% |
95,037
+10,546
| +12% | +$120K |
|
2021
ePlus
PLUS
$2.02B
| $1.08M | ﹤0.01% |
29,434
-94,104
| -76% | -$3.45M |
|
|
IBTX
2022
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.08M | ﹤0.01% |
24,389
+3,519
| +17% | +$156K |
|
|
ESGR
2023
DELISTED
Enstar Group
ESGR
| $1.08M | ﹤0.01% |
6,670
+493
| +8% | +$79.6K |
|
|
SUM
2024
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.08M | ﹤0.01% |
66,214
+3,649
| +6% | +$59.4K |
|
2025
Howard Hughes
HHH
$4.95B
| $1.07M | ﹤0.01% |
19,560
-91,392
| -82% | -$5.02M |
|